AI assistant
Morepen Laboratories Ltd. Capital/Financing Update 2020
59389_rns_2020-10-10_e8ada5c9-0b5f-4754-ab67-6aa889895c8d.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
To,
National Stock Exchange of India Ltd. Exchange Plaza, Bandra Kurla Complex, Sandra (East), Mumbai- 400 051 Tel No: (022) 26598100 - 8114 Fax No: (022) 26598120 Symbol: MOREPENLAB
BSE Limited
Floor 25, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 00 I Phones: 91-22-22721233/4 Fax: 91-22-2272 3121 Scrip Code: 500288
Subject: Outcome of the Board Meeting held on 101 h October, 2020 Ref.: Intimation under Regulation 30 and other applicable Regulations of SEBI (Listing Obligations & Disclosure Requirements), Regulations 2015, as amended .
. Dear Sir,
This is to inform you that the Board of Directors of the Company, in their meeting held on Saturday, 10111 October, 2020 (Timings: Meeting commenced at 11.00 a.m. and concluded at 1.00 p.m.) have, inter-alia, subject to approval of members of the Company, considered and approved issue and allotment of up-to 16,85,00,000 (Sixteen Crore Eighty-Five Lakh) Fully Convertible Warrants ('Warrants') to the entities belonging to Promoter Group of the Company, at a price of Rs. 25/- (Rupees Twenty-Five Only) per Warrant, aggregating up-to Rs. 421,25,00,000/- (Rupees Four Hundred Twenty-One Crore and Twenty-Five Lakh Only) carrying right by the Warrant holder to conve11 and subscribe 1 (One) Equity Share of Rs. 2/- (Rupees Two Only) each against each Warrant, at a price of Rs. 25/- (Rupees Twenty-Five Only) (including the warrant subscription price and the warrant exercise price) per share, on a preferential basis in accordance with SEBI (f CDR) Regulations, 2018 and other applicable laws.
An Extraordinary General Meeting of the members of the Company will be held on Thursday, November 05, 2020, through Video Conferencing/ Other Audio Video Means, for seeking approval of the members for the said preferential issue.
The requisite details as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 with respect to the Preferential Issue of Warrants is enclosed as Annexure A.
Kindly acknowledge the receipt and take it on your record.
Thanking you, Yours faithfully, For Morepen Laboratori~s Limited
~~~· (Vipul Gmar Srivastava)
Company Secretary
Encl.: As Above
Morepen Laboratories Limited
Corp. Off.: 4th Floor,Antriksh Bhawan, 22 K.G.Marg, New Delhi- 110 001, INDIA Tel.:+91-11-23324443,23712025, E-mail: [email protected],Website:www.morepen.com CIN NO. L24231 HP1984PLC006028
Plant & Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205 Tel.: +91-1795-266401-03, 244590, Fax: +91-1795-244591, E-mail: [email protected]
Annexure-A
Disclosure pursuant to SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read with SEBI circular no. CIR/CFD/CMD/4/2015 dated September 09, 2015;
| S. no. | Particulars | Information |
|---|---|---|
| 1. | Type of securities proposed to be issued (viz. equity shares, convertibles etc.) |
Fully CGnvertible Warrants ("Warrants"). Each Warrant will be convertible into 1 (One) Equity Share of the face value of Rs. 2/- (Rupees Two Only) each . |
| 2. | Type of issuance (futiher public offering, rights issue, depository receipts (ADR/GDR), qualified Institutions placement, preferential allotment etc.) |
Preferential allotment |
| 3. | Total number of securities proposed to be issued or the total amount for which the securities will be issued (approximately) |
16,85,00,000 (Sixteen Crore Eight Five y Lakh) Warrants convertible into or exchangeable for 1 (One) Equity Share of face value of Rs. 2/- (Rupees Two Only) each |
| (The total amount of investment into the Company would be up-to Rs. 421 ,25,00,000/- (Rupees Four Hundred Twenty-One Crore and Twenty Five Lakh Only). |
||
| 4. | In case of preferential issue, the listed entity shall disclose the following |
1. Brook Investments & Financial Services Pvt. Ltd. - 35,00,000 Warrants. |
| additional details to the stock exchange(s): |
2. Concept Credits & Consultants Pvt. Ltd. - 35,00,000 Warrants. 3. Epitome Holdings Private Limited |
|
| i) Names of the investors; | 35,00,000 Warrants. 4. Scope Credits & Financial Services Pvt. |
|
| Ltd. - 35,00,000 Warrants. & 5. Mid-Med Financial Services Investments Pvt. Ltd. - 35,00,000 |
||
| Warrants. 6. React Investments & Financial Services Pvt. Ltd. - 35,00,000 Warrants. |
||
| 7. Solitary Investments & Financial Services Pvt. Ltd. - 35,00,000 Warrants. |
||
| 8. Square Investments & Financial Services Pvt. Ltd. - 35,00,000 Warrants. |
||
| 9. Solace Investments & Financial Services Pvt. Ltd. - 35,00,000 Warrants. |
||
| 1 O.Seed Securities & Services Pvt. Ltd. - 35,00,000 Warrants. 11.Liquid Holdings Pvt. Ltd. - |
||
| 13,35,00,000 Warrants. ; |
. Morepen Laboratories Limited
Corp. Off.: 4th Floor,Antriksh Bhawan, 22 K.G.Marg, New Delhi- 110 001 INDIA Tel.:+91-11-23324443,23712025, E-mail: [email protected] Webs'ite:www.morepen com CIN NO. L24231 HP1984PLC006028 ' .
Plant & Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.)-173205 Tel.: +91-1795-266401-03, 244590, Fax: +91-1795-244591, E-mail: [email protected]
ii) Post allotment of securities outcome of the subscription, issue price I allotted price (in case of convertibles), number of investors;
iii) In case of convertibles - intimation on conversion of securities or on lapse of the tenure of the instrument;
Total number of investors: 11 (Eleven)
The warrants will be issued at a price of not lower than the price specified under SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. Warrant would be allotted only upon payment of 25% of the price of warrant at the time of allotment.
Each warrant is convertible into (1) One Equity Share and the conversion can be exercised at any time within a period of 18 months from the date of allotment, in one or more tranches, as the case may be and on such other terms and conditions as applicable.
Option for conversion of warrants into Equity Shares will be available upon payment of full price of warrant before such exercise of option.
The requisite intimation will be given at the time of conversion of warrants.
Morepen Laboratories Limited
Corp. Off.: 4th Floor,Antriksh Bhawan, 22 K.G.Marg, New Delhi-110 001, !NOIA Tel.:+91-11-23324443,23712025, E-mail: [email protected],Website:www.morepen.com CIN NO. L24231 HP1984PLC006028
Plant & Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205 Tel.: +91-1795-266401-03, 244590, Fax: +91-1795-244591, E-mail: [email protected]
